Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
bb2121 for Multiple Myeloma
Recruiting3 awardsPhase 2
Scottsdale, Arizona
This trial is testing a new treatment for myeloma that has relapsed or is refractory. The trial will enroll approximately 235 subjects in 3 different cohorts.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.